These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 27054294)

  • 1. Design, synthesis and biological evaluation of pyrido[2,3-d]pyrimidin-7-(8H)-ones as HCV inhibitors.
    Camarasa M; Puig de la Bellacasa R; González ÀL; Ondoño R; Estrada R; Franco S; Badia R; Esté J; Martínez MÁ; Teixidó J; Clotet B; Borrell JI
    Eur J Med Chem; 2016 Jun; 115():463-83. PubMed ID: 27054294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of N-phenylthieno[2,3-d]pyrimidin-4-amines as inhibitors of FGFR1.
    Gryshchenko AA; Bdzhola VG; Balanda AO; Briukhovetska NV; Kotey IM; Golub AG; Ruban TP; Lukash LL; Yarmoluk SM
    Bioorg Med Chem; 2015 May; 23(9):2287-93. PubMed ID: 25817240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.
    Krueger AC; Madigan DL; Beno DW; Betebenner DA; Carrick R; Green BE; He W; Liu D; Maring CJ; McDaniel KF; Mo H; Molla A; Motter CE; Pilot-Matias TJ; Tufano MD; Kempf DJ
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2212-5. PubMed ID: 22342631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrido[2,3-
    Jubete G; Puig de la Bellacasa R; Estrada-Tejedor R; Teixidó J; Borrell JI
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31744155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening.
    Chaudhuri R; Lee H; Truong L; Torres J; Patel K; Johnson ME
    J Chem Inf Model; 2012 Aug; 52(8):2245-56. PubMed ID: 22697413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-(3-chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors.
    Sakamoto T; Koga Y; Hikota M; Matsuki K; Mochida H; Kikkawa K; Fujishige K; Kotera J; Omori K; Morimoto H; Yamada K
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1431-5. PubMed ID: 25754491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel substituted pyrimidines as HCV replication (replicase) inhibitors.
    Kwong CD; Clark JL; Fowler AT; Geng F; Kezar HS; Roychowdhury A; Reynolds RC; Maddry JA; Ananthan S; Secrist JA; Shih NY; Piwinski JJ; Li C; Feld B; Huang HC; Tong X; George Njoroge F; Arasappan A
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1160-4. PubMed ID: 22178556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel condensed pyrrolo[1,2-c]pyrimidines featuring morpholine moiety as PI3Kα inhibitors.
    Ibrahim MA; Abou-Seri SM; Hanna MM; Abdalla MM; El Sayed NA
    Eur J Med Chem; 2015 Jun; 99():1-13. PubMed ID: 26037808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase.
    Ruebsam F; Murphy DE; Tran CV; Li LS; Zhao J; Dragovich PS; McGuire HM; Xiang AX; Sun Z; Ayida BK; Blazel JK; Kim SH; Zhou Y; Han Q; Kissinger CR; Webber SE; Showalter RE; Shah AM; Tsan M; Patel RA; Thompson PA; Lebrun LA; Hou HJ; Kamran R; Sergeeva MV; Bartkowski DM; Nolan TG; Norris DA; Khandurina J; Brooks J; Okamoto E; Kirkovsky L
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6404-12. PubMed ID: 19818610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the Diversity at the C-4 Position of Pyrido[2,3-
    Masip V; Lirio Á; Sánchez-López A; Cuenca AB; Puig de la Bellacasa R; Abrisqueta P; Teixidó J; Borrell JI; Gibert A; Estrada-Tejedor R
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-HCV determinant motif identification in pyranone carboxamide scaffold.
    Balaraju T; Konreddy AK; Parveen A; Toyama M; Ito W; Karampuri S; Baba M; Sharon A; Bal C
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5224-7. PubMed ID: 26483202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest.
    Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA
    Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of nucleosides of 5,7-disubstituted pyrido [2,3-d] pyrimidines and their antibacterial activity.
    Gupta A; Prakash L
    Boll Chim Farm; 1994 Mar; 133(3):163-6. PubMed ID: 8011277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and molecular modelling studies of 8-arylpyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors.
    Loidreau Y; Deau E; Marchand P; Nourrisson MR; Logé C; Coadou G; Loaëc N; Meijer L; Besson T
    Eur J Med Chem; 2015 Mar; 92():124-34. PubMed ID: 25549552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diversity oriented, microwave assisted synthesis of N-substituted 2-hydro-4-amino-pyrido[2,3-d]pyrimidin-7(8H)-ones.
    Mont N; Teixidó J; Borrell JI
    Mol Divers; 2009 Feb; 13(1):39-45. PubMed ID: 19037737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
    Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
    Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
    Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
    Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors.
    He H; Wang W; Zhou Y; Xia Q; Ren Y; Feng J; Peng H; He H; Feng L
    Bioorg Med Chem; 2016 Apr; 24(8):1879-88. PubMed ID: 26972920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides.
    Januszczyk P; Fogt J; Boryski J; Izawa K; Onishi T; Neyts J; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):713-23. PubMed ID: 20183611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 1-phenyl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides inhibit hepatitis C virus replication via suppression of cyclooxygenase-2.
    Manvar D; Pelliccia S; La Regina G; Famiglini V; Coluccia A; Ruggieri A; Anticoli S; Lee JC; Basu A; Cevik O; Nencioni L; Palamara AT; Zamperini C; Botta M; Neyts J; Leyssen P; Kaushik-Basu N; Silvestri R
    Eur J Med Chem; 2015 Jan; 90():497-506. PubMed ID: 25483263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.